Skip to main content
. 2020 Jun 19;26(4-5):233–244. doi: 10.1159/000508304

Table 2.

Comparison of SU and SUDs at 5-year follow-up by screened ADHD status

ADHD S− % (n/N)a ADHD S+ % (n/N)a χ2
Alcohol
 Drinking alcohol 93.2 (4,109/4,410) 94.3 (181/192) 0.20
 Binge drinking 37.2 (1,641/4,406) 45.3 (87/192) 4.76*
 AUD 8.2 (359/4,401) 20.8 (40/192) 35.69***
Tobacco
 Cigarette smoking 39.7 (1,749/4,410) 54.2 (104/192) 15.50***
 Nicotine dependence 9.5 (413/4,361) 16.1 (31/192) 8.57**
Cannabis
 Cannabis use 28.8 (1,268/4,406) 46.4 (89/192) 26.48***
 CUD 7.8 (345/4,407) 15.6 (30/192) 13.91***
Illicit drugs
 Hallucinogens 4.3 (190/4,404) 10.4 (20/192) 14.34***
 Meth-/amphetamines 3.7 (163/4,405) 10.4 (20/192) 19.99***
 Ecstasy/MDMA 7.3 (321/4,405) 16.7 (32/192) 21.53***
 Cocaine/crack/freebase 5.8 (256/4,406) 14.1 (27/192) 20.29***
Non-medical use of prescription drugs
 ADHD medication 1.7 (74/4,402) 7.3 (14/192) 28.15***
 Sedatives 5.2 (231/4,402) 14.1 (27/191) 25.63***

Hallucinogens include psilocybin (“magic mushrooms”), LSD, and PCP; ADHD medication includes methylphenidate and amphetamine sulphate; sedatives include tranquilisers and hypnotics. Heroin was excluded due to small sample sizes. ADHD, attention deficit/hyperactivity disorder; ADHD S–, ADHD screened negative group (ASRS score <14); ADHD S+, ADHD screened positive group (ASRS score ≥14); ASRS, Adult ADHD Self-Report Scale; SU, substance use; SUD, substance use disorder; AUD, alcohol use disorder; CUD, cannabis use disorder.

*

p < 0.05

**

p < 0.01

***

p < 0.001.

a

n/N = number of participants who use the substance/total number of participants of the corresponding subgroup.